Search results for

James Nurton reports on a discussion about standard-essential patents and FRAND terms at the AIPPI Congress in Rio de Janeiro

Laurent Thibon is half-way through his term as AIPPI Secretary General. He spoke to James Nurton about changes to the structure of the association – and to his own role

The Patent Trial and Appeal Board has instituted four of the Coalition for Affordable Drugs’ IPR petitions challenging Celgene patents, bringing the total number its petitions instituted to seven and greatly shifting the success rate of what one law firm calls the “PTAB Crashers”

Managing IP was reporting from the American Intellectual Property Law Association’s Annual Meeting in Washington DC last week. Here are some of the topics, tidbits and takeaways from the meeting

The Preparatory Committee has published the final version of the Rules of Procedure for the Unified Patent Court, including changes to the rules on opt outs and language

An amicus brief aimed at reducing the Eastern District of Texas’s dominance, Canadian concerns over the Trans-Pacific Partnership, limited exceptions to the DMCA being announced, SAP and Google reaching a patent agreement, and George Orwell’s estate making an ironic demand were in the IP headlines in the past week

There is a good chance of a “Judge Judy”-like small copyright claims tribunal being established in the United States, according to one speaker at the AIPLA Annual Meeting

The first Unitary Patents may be granted one year from now. Following our series of articles on the Unitary Patent and UPC, James Nurton and Kingsley Egbuonu take stock of where we are now and what remains to be done before Europe’s new patent system can come into effect

The World Intellectual Property Organisation (WIPO) has announced that the Republic of the Gambia has acceded to the Madrid Protocol on the international registration of trade marks. The notification says that the Madrid Protocol will enter into force in Gambia on December 18 2015. This makes Gambia the 21st African country or regional organisation to join the Madrid Protocol.

The High Court in D'Arcy v Myriad Genetics [2015] HCA 35 has unanimously found that isolated naturally-occurring nucleic acids coding for mutant or polymorphic genes does did not amount to patentable subject matter in Australia.